Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.aristobiotech.com | |
Market Cap | 43.43 Cr. | |
Enterprise Value(EV) | 68.50 Cr. | 2022-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 2.13 | Trailing Twelve Months Ending 2022-03 |
Price-Earning Ratio (PE) | 29.96 | Trailing Twelve Months Ending 2022-03 |
Industry PE | 22.56 | Trailing Twelve Months Ending 2022-03 |
Book Value / Share | 40.96 | Trailing Twelve Months Ending 2022-03 |
Price to Book Value | 1.56 | Calculated using Price: 63.80 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 0.68 Cr. | 6,807,800 Shares |
FaceValue | 10 |
1 Day |
|
+4.16% |
1 Week |
|
+2.90% |
1 Month |
|
+7.41% |
3 Month |
|
+0.47% |
6 Month |
|
|
1 Year |
|
|
2 Year |
|
|
5 Year |
|
|
10 Year |
|
4 years | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 25.03 | 8.54 | 8.38 | 10.28 | |
Return on Capital Employed (%) | 24.67 | 13.84 | 11.27 | 11.60 | |
Return on Assets (%) | 3.12 | 1.13 | 1.27 | 1.83 |
Particulars | 4 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Shh. Funds | 11 | 12 | 13 | 15 | |
Non Curr. Liab. | 7 | 11 | 12 | 11 | |
Curr. Liab. | 72 | 65 | 56 | 51 | |
Minority Int. | |||||
Equity & Liab. | 91 | 88 | 81 | 77 | |
Non Curr. Assets | 10 | 11 | 12 | 14 | |
Curr. Assets | 81 | 77 | 69 | 63 | |
Misc. Exp. not W/O | |||||
Total Assets | 91 | 88 | 81 | 77 |
Particulars | 4 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Net Sales | 202 | 201 | 167 | 166 | |
Other Income | 0 | 0 | 0 | 0 | |
Total Income | 202 | 201 | 167 | 166 | |
Total Expenditure | -195 | -197 | -163 | -161 | |
PBIDT | 7 | 5 | 5 | 6 | |
Interest | -2 | -3 | -2 | -2 | |
Depreciation | -1 | -1 | -1 | -1 | |
Taxation | -1 | 0 | 0 | -1 | |
Exceptional Items | 0 | ||||
PAT | 3 | 1 | 1 | 1 | |
Adjusted EPS | 6 | 2 | 2 | 3 |
Particulars | 4 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 8 | 1 | 2 | 7 | |
Cash Fr. Inv. | -2 | -2 | -2 | -3 | |
Cash Fr. Finan. | -6 | 1 | -1 | -3 | |
Net Change | 0 | 0 | 0 | 0 | |
Cash & Cash Eqvt | 0 | 1 | 0 | 0 |
No Corporate Announcement found. |
Mon, 29 May 2023 |
|
|
|
|
|